1180P - Combination of pegilodecakin and docetaxel shows synergy in tumor rejection in immune resistant TNBC model

Autor: Ratti, N., Shifrin, N., McCauley, S., Verma, R., Van Vlasselaer, P., Oft, M., Leveque, J.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect